Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir

NCT05423834 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

1800

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Tenofovir alafenamide
DRUG: Entecavir

Sponsor

Chinese University of Hong Kong